FindTrial
Sign In

A study to see if exosome therapy can help people with hair loss (alopecia) grow back their hair

The Role of Exosomes in Hair Follicle Growth: A Novel Therapeutic Approach for Alopecia - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091303
Enrollment
30
Registered
2025-07-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Intervention1: Exosomes: Intra-dermal injection of platelet-derived exosome-enriched plasma into alopecic scalp areas. Administered once every 2 weeks for a total of 3 sittings. Intervention2: Nil: Ni

Sponsors

Manav Rachna Dental College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed with mild to severe alopecia No history of other scalp disorders, autoimmune diseases, or active scalp infections Willing to comply with study protocols and follow-up visits

Exclusion criteria

Exclusion criteria: History of chemotherapy or radiation therapy within the last year Presence of active skin or scalp infections Pregnant or breastfeeding women

Design outcomes

Primary

MeasureTime frame
Hair density (visually assessed)Timepoint: 3 months and 6 months after last injection.—

Secondary

MeasureTime frame
Quality of life using patient-reported outcomesTimepoint: At 6 months after the last injection of exosome—

Countries

India

Contacts

Public ContactNeeraj Bansal

Manav Rachna Dental College

doc.neerajbansal@gmail.com9971338761

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026